loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2017_111___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Midas Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MIDAS PHARMA GMBH Ingelheim am Rhein DE (1)

    filter

    01 Doxazosin mesilate (1)

    filter

    01 Germany (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    MIDAS PHARMA GMBH Ingelheim am Rhei...

    Contact Supplier
    • EDQM
    Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Doxazosin mesilate

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2017-111 - Rev 03
    Valid
    Chemical
    2023-09-20
    2125
    Midas Pharma

    API China 2024

    Attending

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for CEP 2017-111 - Rev 03 of Midas Pharma Gmbh Ingelheim Am Rhein De

    Looking for Certificates of Suitability (CEPs) for CEP 2017-111 - Rev 03 of Midas Pharma Gmbh Ingelheim Am Rhein De 1

    20

    Midas Pharma Gmbh Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from EDQM.

    They are recognized for Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    One of their significant offerings is Doxazosin mesilate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-111 - Rev 03

    This Chemical Type CEP, issued on September 20, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2125 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY